Condition
SICCA SYNDROME
Total Trials
5
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed4
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05715463Not ApplicableActive Not Recruiting
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
NCT04206826Not ApplicableCompletedPrimary
Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The "PREDELFI" Clinical Pilot Study
NCT04793646Not ApplicableCompleted
N-acetylcysteine for Primary Sjögren's Syndrome
NCT02422407Completed
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome
NCT02066896Not ApplicableCompleted
Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome
Showing all 5 trials